BX Home
Food and Drug Administration
FDA panel backs first non-drug asthma treatment

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

Register using your

account Register for Beta

FOOD AND DRUG ADMINISTRATION back to topic

FDA panel backs first non-drug asthma treatment

The Food and Drug Administration's panel of respiratory device experts voted 6-1 that Asthmatx's Alair System be approved under certain conditions, including long-term tracking of patients. The company's procedure...

San Jose Mercury News. Published on October 28, 2009

Read the full Article

report

save

Reactions to FDA panel backs first non-drug asthma treatment

Date

Type Channel Author

Search Cancel

McGraw-Hill Education Standard & Poors BusinessWeek Platts McGraw-Hill Construction AviationWeek McGraw-Hill Broadcasting J.D. Power

FDA panel backs first non-drug asthma treatment

Reactions to FDA panel backs first non-drug asthma treatment

Join Business Exchange

Member sign in

ALSO IN THIS TOPIC Food and Drug Administration